Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

DU Knib 250mg Tablet

Prescription Icon
Prescription Required

Marketer

Sayre Therapeutics Pvt Ltd

Salt Composition

Lapatinib (250mg)

Overview DU Knib 250mg Tablet

Knib 250mg tablets are indicated for breast cancer management. Their mechanism involves inhibiting or reducing the proliferation of cancerous cells. This medication is administered either solely or alongside other therapies in advanced breast cancer. Optimal absorption requires ingestion on an empty stomach, or one hour prior to, or two hours after, meals. Dosage and treatment length are personalized based on individual disease severity and therapeutic response. Strict adherence to the prescribed regimen is vital to minimize adverse effects. While benefits may not be immediately apparent (requiring weeks or months), discontinuation should only occur under physician guidance. Common side effects include nausea, headache, back pain, and respiratory distress. Severe diarrhea necessitates increased fluid intake or medical consultation. Regular blood pressure monitoring may be necessary. Report severe headaches, confusion, visual disturbances, nausea, or vomiting to your doctor immediately. Liver function assessments are typically conducted before, during, and after treatment. Prior to commencing treatment, disclose any liver or kidney ailments. Potential drug interactions necessitate informing your healthcare provider of all medications currently being used. This medication is contraindicated during pregnancy and lactation. Employing effective contraception is crucial for both partners throughout the treatment period to prevent conception.

Primary Ingredients of DU Knib 250mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of DU Knib 250mg Tablet

Malignant breast tumor

Major Benefits of DU Knib 250mg Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer DU Knib 250mg Tablet on an empty stomach.

Common Side effects of DU Knib 250mg Tablet:

  • Abdominal pain
  • Back pain
  • Breathing problems
  • Constipation
  • Cough
  • Diarrhea
  • Fatigue
  • Headache
  • Hot flashes
  • Increased bilirubin in the blood
  • Insomnia (difficulty in sleeping)
  • Joint pain
  • Liver damage
  • Loss of appetite
  • Mucosal inflammation
  • Nausea
  • Pain in extremities
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weakness
  • Weight gain

How to use DU Knib 250mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer DU Knib 250mg Tablet on an empty stomach.

How DU Knib 250mg Tablet works:

DU Knib 250mg tablets are prescribed for cancer treatment. Their mechanism of action targets HER2 and EGFR receptors, proteins that trigger excessive cell growth. By binding to these receptors, the drug blocks the signaling pathways that drive cancer cell proliferation.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside DU Knib 250mg Tablet may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Employing DU Knib 250mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.

Breast feedingBreast feedingUNSAFE

Lactation and DU Knib 250mg tablets are incompatible; the medication poses a potential toxicity risk to the nursing infant.

DrivingDrivingUNSAFE

Taking a DU Knib 250mg Tablet might impair your driving ability due to potential side effects.

KidneyKidneyCAUTION

Exercise caution when administering DU Knib 250mg Tablets to individuals with severe kidney impairment; dosage modification may be necessary. Consult a physician. Data regarding DU Knib 250mg Tablet use in such patients is limited. Dosage alteration is not advised for those with mild to moderate kidney disease.

LiverLiverCAUTION

Caution is advised when administering 250mg DU Knib tablets to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Data regarding the drug's use in patients exhibiting severe liver dysfunction are scarce.

What if you forget to take DU Knib 250mg Tablet :

Omit a DU Knib 250mg Tablet dose? Seek your physician's advice.

Facts to Know About DU Knib 250mg Tablet

LabelValue
Chemical Type Quinazoline Amine Derivative
Developing Habits No.
Treatment Category Cancer Medications
Actions Tyrosine kinase inhibitor drugs

FAQs on DU Knib 250mg Tablet

No, this is a targeted anti-cancer drug. Unlike chemotherapy, it acts through a more specific mechanism. DU Knib 250mg Tablet is a tyrosine kinase inhibitor that blocks the activity of abnormal proteins driving cancer cell growth, thus hindering or slowing cancer progression.
DU Knib 250mg Tablets are used in combination with other anti-cancer medications. Specifically, it's commonly combined with capecitabine for treating advanced breast cancer in patients previously receiving chemotherapy, and with letrozole for post-menopausal women with breast cancer.
Always take DU Knib 250mg tablets as prescribed by your doctor. Swallow each tablet whole with water, at the same time daily, either one hour before or one hour after meals, maintaining consistent timing relative to food intake (e.g., one hour before breakfast).
DU Knib 250mg Tablets can cause potentially severe or life-threatening liver damage, developing anywhere from days to months after treatment begins. Disclose any history of liver disease to your doctor. Seek immediate medical attention if you experience symptoms like jaundice (yellowing skin or eyes), dark urine, light-colored stools, abdominal pain (upper right), unusual bleeding or bruising, or itching.
Experience diarrhea while taking DU Knib 250mg Tablets? Drink 8-10 glasses of fluids daily (water, sports drinks, clear liquids). Choose low-fat, high-protein foods over fatty or spicy options. Opt for cooked vegetables and peeled fruits. Avoid milk products and herbal supplements. If diarrhea continues, contact your doctor; treatment may be adjusted.
Your doctor will monitor your skin throughout your treatment. For sensitive skin, use fragrance-free, hypoallergenic, soap-free cleansers and cosmetics. Apply sunscreen with SPF 30 or higher. Report any rash to your doctor immediately.
Additional heart and liver function tests may be necessary. DU Knib 250mg Tablet can alter your heart's rhythm and blood flow, necessitating close monitoring by your doctor. Liver function will also be assessed. Dosage adjustments or treatment discontinuation will depend on these test results.
Prevent pregnancy while taking DU Knib 250mg tablets by using reliable contraception. Continue using contraception for at least one week after your final dose. Contact your doctor immediately if you become pregnant; they will determine if treatment should continue.
DU Knib 250mg Tablet
6,649
MRP 8,100
17% off